Status: Recruiting
Novel Subtypes and Treatment Strategies of Patients with Unresectable Combined Hepatocellular Cholangiocarcinoma Based on Multimodal Data
This study focused on exploring new comprehensive treatment strategies for patients with unresectable combined hepatocellular-cholangiocarcinoma, classifying patients with CHC subtypes based on the combination of artificial intelligence and multi-omics, and exploring the optimal treatment strategies for patients with different subtypes, helping clinicians to screen the most beneficial groups of various treatment schemes, and providing new ideas for safe treatment of high-risk patients.
Participants needed: 198
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Zhongda HospitalUpdated: Feb 27, 2025Locations: 1
Eligibility criteria
age ≥18 years; diagnosis of CHC confirmed by histology or cytology; [+4]
pregnant women, lactating women, and men and women of childbearing age who are u... [+5]